InViVo
-
Neuro
InVivo to Initiate Cervical Spinal Cord Injury Study
March 23, 2017 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that Health Canada has approved the company’s Investigational Testing…
Read More » -
Biologics
InVivo Therapeutics Announces Sixth Patient Conversion in The INSPIRE Study of the Neuro-Spinal Scaffold™
CAMBRIDGE, Mass.–(BUSINESS WIRE)– InVivo Therapeutics Holdings Corp. (NVIV) today announced that the patient enrolled in December in the INSPIRE study of…
Read More » -
Biologics
InVivo Therapeutics Announces INSPIRE’S 29th Clinical Site: Rhode Island Hospital
January 10, 2017 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that Rhode Island Hospital in Providence, RI has been…
Read More » -
Biologics
InVivo Therapeutics Responds to PixarBio Announcement
January 03, 2017 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today issued a response to a PixarBio Corporation press release dated…
Read More » -
Biologics
InVivo Therapeutics Announces New Patient Enrollment into the INSPIRE Study
December 20, 2016 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that a new patient with a T8-9 fracture dislocation…
Read More » -
Biologics
InVivo Therapeutics Appoints Melanie Morel-Ferris, C.P.A. as Interim CFO, Replacing Steven McAllister in Role
December 08, 2016 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced the resignation of Steven McAllister from the position…
Read More » -
Financial
InVivo Therapeutics Reports 2016 Third Quarter Financial Results and Business Update
November 04, 2016 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today reported financial results for the quarter ended September 30,…
Read More » -
Biologics
InVivo Therapeutics Announces Appointment of Jeffrey Hatfield to Board of Directors
November 02, 2016 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced the appointment of Jeffrey Hatfield to its Board of…
Read More » -
Biologics
InVivo Therapeutics Announces Foothills Medical Centre in Calgary, Alberta as New Canadian Site for INSPIRE Study
October 19, 2016 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that the Foothills Medical Centre in Calgary, Alberta has…
Read More » -
Biologics
InVivo Therapeutics to Present at 55th International Spinal Cord Society Annual Scientific Meeting
September 07, 2016 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that Kristin Neff, Vice President of Clinical Operations &…
Read More » -
Neuro
InVivo Therapeutics Announces Fifth Patient Conversion in INSPIRE Study of the Neuro-Spinal Scaffold™
August 17, 2016 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that the ninth patient implanted with the Neuro-Spinal Scaffold™…
Read More » -
Neuro
Pamela Stahl appointed chief commercial officer of InVivo Therapeutics
15th August 2016 InVivo Therapeutics Holdings has appointed Pamela Stahl to the newly-created position of chief commercial officer, effective September…
Read More » -
Financial
InVivo Therapeutics Q2 meets the street, shares stay steady
August 5, 2016 – By FINK DENSFORD InVivo Therapeutics (NSDQ:NVIV) shares stayed steady after the company released 2nd quarter earnings that met…
Read More » -
Biologics
InVivo Therapeutics Announces Ben Taub Hospital/Baylor College of Medicine as New Site for INSPIRE Study
July 18, 2016 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that the Ben Taub Hospital in Houston, TX…
Read More » -
Spine
InVivo Therapeutics touts case study in 1st spine scaffold implant
JUNE 24, 2016 – BY BRAD PERRIELLO InVivo Therapeutics (NSDQ:NVIV) this week touted a case study of the 1st implantation of…
Read More »